Clinical TrialsSearch results
Number of results: 316
Other
- Prevention of VZV reactivation using long-term low-dose valacyclovir after allogeneic hematopoietic stem cell transplantation.
- allogeneic hematopoietic stem cell transplantation recipients
- Japan Hematology & Oncology Clinical Study Group (J-HOCS)
- 2006-03-10
Other
- Prednisolone therapy of the first episode of idopatic nephrotic syndrome in children: A Multi-center randomized controlled trial
- Idiopatic nephrotic syndrome in children
- Japanese Study Group of Kidney Disease in Children
- 2007-09-01
Other
- Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06)
- Steroid-sensitive nephrotic syndrome
- Japanese Study Group of Renal Disease in Children(JSRDC)
- 2006-04-01
Other
- Prediction of drug adverse event through gene expression analysis
- embedded dens molaris
- JICHI MEDICAL UNIVERSITY
- 2007-04-05
Recruiting
- Preceding Study Toward Establishing Optimal Blood Concentrations of Mycophenolate Mofetil
- Pediatric steroid-resistant nephrotic syndrome Pediatric renal transplant recipients
- Ono Marika
- 2024-03-20
Other
- Post-marketing study of cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison with Aspirin
- Patients with cerebral infarction (excluding cardiogenic cerebral embolism)
- Otsuka Pharmaceutical Co., Ltd.
- 2005-09-13
Completed
- PIANO study
- multiple myeloma
- Kanda Yoshinobu
- 2019-03-18
Other
- PhaseII trial of erlotinib for elderly patients with advanced or recurrent non-small cell lung cancer
- Non-small cell lung cancer
- Keio University School of Medicine Division of Pulmonary Medicine
- 2009-04-11
Recruiting
- Phase two clinical trial of limited stage lymphoblastic lymphoma.
- Limited stage lymphoblastic lymphoma
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26
Recruiting
- Phase III, Open-label, Study of First-line Dato-DXd in Combination WithRilvegostomig for Advanced Non-squamous NSCLC With High PD-L1Expression (TC>=50%) and Without Actionable Genomic Alterations
- Non-Small Cell Lung Cancer
- Hibi Kazushige
- 2024-05-20